Premium
Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis
Author(s) -
Negro Francesco,
Samii Kaveh,
RubbiaBrandt Laura,
Quadri Rafael,
Male PierreJean,
Zarski JeanPierre,
Baud Marilyn,
Giostra Emile,
Beris Photis,
Hadengue Antoine
Publication year - 2000
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/(sici)1096-9071(200001)60:1<21::aid-jmv4>3.0.co;2-f
Subject(s) - siderosis , hemochromatosis , hereditary hemochromatosis , hepatitis c , hepatitis c virus , medicine , liver disease , gastroenterology , fibrosis , pathology , immunology , virus
Chronic hepatitis C is often associated with liver iron overload, which may affect the long‐term prognosis and the response to antiviral treatment. The occurrence of hemochromatosis (HFE) mutations were studied to determine whether may contribute to the liver iron overload of chronic hepatitis C patients. The prevalence of two HFE mutations (C282Y and H63D) in 120 chronic hepatitis C patients was determined and the findings were correlated with clinical, histological and virological features. Hepatic iron was determined semiquantitatively by a histochemical hepatic iron index, defined as the ratio of a histochemical staining score to the patient's age, after correction for heterogeneous lobular iron distribution. Serum hepatitis C virus (HCV) RNA was measured by bDNA assay and typed by restriction fragment length polymorphism. Liver HCV RNA was measured by a semi‐quantitative strand‐specific reverse transcription‐polymerase chain reaction (RT‐PCR). Excess liver iron was stained in the liver of 36 patients (30%). Siderotic patients had the same geographic origin, serum and liver HCV RNA levels and H63D and C282Y mutations frequency as non‐siderotic patients. However, siderotic patients were older ( P = 0.015), more frequently males ( P = 0.02), less frequently infected with HCV genotype 3 ( P = 0.037) and had a higher liver fibrosis score ( P = 0.008). The liver iron content did not correlate with the serum or liver HCV RNA titers. Ten of the 36 patients with liver siderosis had neither a history of excess alcohol intake, multiple transfusions, or HFE mutations. In conclusion, the pathogenesis of the liver iron overload in chronic hepatitis C patients cannot be fully explained by the occurrence of HFE mutations. The exact mechanism of iron accumulation in these patients therefore remains unexplained. J. Med. Virol. 60:21–27, 2000. © 2000 Wiley‐Liss, Inc.